Newbridge Financial Services Group’s Bicycle Therapeutics BCYC Stock Holding History

Newbridge Financial Services Group’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-40	Closed	-$804	–	1171
2023 Q3	$804	Hold	40	–	–	﹤0.01%	1172
2023 Q2	$1.02K	Hold	40	–	–	﹤0.01%	1216
2023 Q1	$851	Hold	40	–	–	﹤0.01%	1288
2022 Q4	$1.18K	Hold	40	–	–	﹤0.01%	1281
2022 Q3	$1K	Hold	40	–	–	﹤0.01%	1270
2022 Q2	$1K	Hold	40	–	–	﹤0.01%	1249
2022 Q1	$2K	Hold	40	–	–	﹤0.01%	1268
2021 Q4	$2K	Hold	40	–	–	﹤0.01%	1218
2021 Q3	$2K	Hold	40	–	–	﹤0.01%	1163
2021 Q2	$1K	Hold	40	–	–	﹤0.01%	1332
2021 Q1	$1K	Buy	+40	New	+$1.03K	﹤0.01%	1235

Other funds holding BCYC

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Newbridge Financial Services Group's BCYC Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of Bicycle Therapeutics (BCYC) in Q4 2023, closing a stake of 40 shares — an estimated $804 sold.

Newbridge Financial Services Group first reported a position in BCYC in Q1 2021 and held it in 11 quarters. The position peaked at $2K in Q1 2022. 101 funds tracked by Wall St. Rank hold BCYC as of Q4 2023.

Newbridge Financial Services Group reported no remaining Bicycle Therapeutics position as of Q4 2023 after selling out during the quarter.
Newbridge Financial Services Group sold 40 Bicycle Therapeutics shares in Q4 2023, an estimated $804.
Newbridge Financial Services Group first reported a position in Bicycle Therapeutics in Q1 2021 and held it in 11 quarters.
Newbridge Financial Services Group's Bicycle Therapeutics position peaked at $2K in Q1 2022.
101 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.